We are monitoring the impact of COVID-19 on Asia-Pacific Neurotherapeutics Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 1199
Share on
Share on

Asia-Pacific Neurotherapeutics Market Research Report – Segmented By Treatment, Disorders, Distribution Channels & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) – Industry Size, Share, Trends & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 1199
Pages: 120

The size of the Asia-Pacific Neurotherapeutics Market is projected to be growing at an aggressive rate during the forecast period. The asia-Pacific market is regarded as an emerging market due to strong economic growth in many developing countries such as China, India, Malaysia.

Neurological disorders result in damage to the brain, spinal nerves that are caused by injury or illness. These disorders can affect men and women, young and old, and people from all cultures at any stage of their life. Most of these disorders involve a progressive decline in physical and mental capabilities that disrupts the patient’s life. So, the changes in the activity of brain can be witnessed due to brain injury, genetic disorders, changing lifestyle and other traumas. Patients suffering from these disorders witnessed varied symptoms such as paralysis, muscle weakness, pain and other disorders. Hence, Neurotherapeutics are used for the treatment of various neurologic disorders.

The factors that are driving the growth of Asia-Pacific Neurotherapeutics Market are increasing aging population, growing R&D expenditure, a better understanding of the nature of neurologic diseases.  Aged population are more susceptible to brain disorders. Therefore, the rise in aging population and life expectancy of the people will increase the market. Restrictions by regulatory bodies on various technologies and drugs, Lack of awareness in developing countries, lack of proper reimbursement policy are the factors that are hampering the growth of the market.

Based on Treatment, the market is segmented into Neurologic drugs and Neurologic devices. Neurologic drugs are further classified into oral administration, injections and others. Whereas neurologic devices are further categorized into Electroconvulsive Therapy (ECT), Vagus Nerve Stimulation (VNS), transcranial magnetic stimulation, Deep Brain Stimulator, and others. Based on disorders, the market is segmented into Central Nervous system (CNS) disorders, Peripheral Nervous system (PNS) disorders, Autonomous Nervous system (ANS) disorders. Based on distribution channels the market is segmented into Hospitals, Neurotherapeutic center, Clinical research organizations, Clinics. Based on Geography, the Asia-Pacific Neurotherapeutics market is analyzed under various regions namely China, Japan, India and Australia.

Some of the key Players dominating the Asia-pacific Neurotherapeutics Market are Abbott Laboratories, Inc., Becton, Novartis AG, Dickinson and Company, Pfizer, Inc., Johnson & Johnson, Biogen, Inc., GlaxoSmithKline, Inc., AstraZeneca plc, Sanofi-Aventis, Spiegelberg, stryker, Covidien, Medtronic, GE healthcare, and Merck & Co.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 Treatment                  

                                5.1.1 Introduction           

                                5.1.2 Neurologic Drugs 

                                                5.1.2.1 Oral Administration

                                                5.1.2.2 Injections

                                                5.1.2.3 Others

                                5.1.3 Neurologic Devices             

                                                5.1.3.1 Electroconvulsive Therapy (ECT)

                                                5.1.3.2 Vagus Nerve Stimulation (VNS)

                                                5.1.3.3 Transcranial magnetic stimulation

                                                5.1.3.4 Deep Brain Stimulator

                                                5.1.3.5 Others

                                5.1.4 Y-o-Y Growth Analysis, By Product

                                5.1.5 Market Attractiveness Analysis, By Product               

                                5.1.6 Market Share Analysis, By Product                

                5.2 Disorders                    

                                5.2.1 Introduction           

                                5.2.2 Central Nervous system disorder  

                                5.2.3 Peripheral Nervous system disorder            

                                5.2.4 Autonomous Nervous system disorder       

                                5.2.5 Y-o-Y Growth Analysis, By Type      

                                5.2.6 Market Attractiveness Analysis, By Type     

                                5.2.7 Market Share Analysis, By Type      

                5.3 Distribution Channels                            

                                5.3.1 Introduction           

                                5.3.2 Hospitals  

                                5.3.3 Neurotherapeutic center  

                                5.3.4 Clinical Research organisations      

                                5.3.5 Clinics        

                                5.3.6 Y-o-Y Growth Analysis, By Application         

                                5.3.7 Market Attractiveness Analysis, By Application        

                                5.3.8 Market Share Analysis, By Application         

6. Geographical Analysis                                              

                6.1 Introduction                              

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Treatment

                                                6.1.3.3 By Disorders

                                                6.1.3.4 By Distribution Channels

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Treatment

                                                6.1.4.3 By Disorders

                                                6.1.4.4 By Distributional Channels

                                6.1.5 Market Share Analysis        

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Treatment

                                                6.1.5.3 By Disorders

                                                6.1.5.4 By Distribution channels

                6.2 China                            

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea               

                6.6 Australia                      

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Abbott Laboratories               

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Becton                         

                8.3 Novartis AG                

                8.4 Dickinson and Company                       

                8.5 Pfizer                            

                8.6 Johnson & Johnson                 

                8.7 Biogen                          

                8.8 Glaxosmithkline                       

                8.9 AstraZeneca               

                8.10 Sanofi Aventis                        

                8.11 Spiegelberg                             

                8.12 Covidien                    

                8.13 Medtronic                

                8.14 GE Health Care                       

                8.15 Merck & Co                              

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia-Pacific Neurotherapeutics Market, By Treatment, From 2021 to 2026 (USD Billion)
  2. Asia-Pacific Neurologic Drugs Market, By Region, From 2021 to 2026 (USD Billion)
  3. Asia-Pacific Neurologic Devices Market, By Region, From 2021 to 2026 (USD Billion)
  4. Asia-Pacific Neurotherapeutics Market, By Disorders, From 2021 to 2026 (USD Billion)
  5. Asia-Pacific Central Nervous system disorders Market, By Region, From 2021 to 2026 (USD Billion)
  6. Asia-Pacific Peripheral Nervous system disorders Market, By Region, From 2021 to 2026 (USD Billion)
  7. Asia-Pacific Autonomous Nervous system disorders Market, By Region, From 2021 to 2026 (USD Billion)
  8. Asia-Pacific Neurotherapeutics Market, By Distribution Channels, From 2021 to 2026 (USD Billion)
  9. Asia-Pacific Hospitals Market, By Region, From 2021 to 2026 (USD Billion)
  10. Asia-Pacific Neurotherapeutic center Market, By Region, From 2021 to 2026 (USD Billion)
  11. Asia-Pacific Clinical research organisations Market, By Region, From 2021 to 2026 (USD Billion)
  12. Asia-Pacific clinics Market, By Region, From 2021 to 2026 (USD Billion)
  13. Japan Neurotherapeutics Market, By Treatment, From 2021 to 2026 (USD Billion)
  14. Japan Neurotherapeutics Market, By Disorders, From 2021 to 2026 (USD Billion)
  15. Japan Neurotherapeutics Market, By Distribution Channels, From 2021 to 2026 (USD Billion)
  16. China Neurotherapeutics Market, By Treatment, From 2021 to 2026 (USD Billion)
  17. China Neurotherapeutics Market, By Disorders, From 2021 to 2026 (USD Billion)
  18. China Neurotherapeutics Market, By Distribution Channels, From 2021 to 2026 (USD Billion)
  19. India Neurotherapeutics Market, By Treatment, From 2021 to 2026 (USD Billion)
  20. India Neurotherapeutics Market, By Disorders, From 2021 to 2026 (USD Billion)
  21. India Neurotherapeutics Market, By Distribution Channels, From 2021 to 2026 (USD Billion)
  22. Asia-Pacific Neurotherapeutics Market, By Neurologic drugs, From 2021 to 2026 (USD Billion)
  23. Asia-Pacific Oral Administrations Market, By Region, From 2021 to 2026 (USD Billion)
  24. Asia-Pacific Injections Market, By Region, From 2021 to 2026 (USD Billion)
  25. Japan Neurotherapeutics Market, By Neurologic drugs, From 2021 to 2026 (USD Billion)
  26. China Neurotherapeutics Market, By Neurologic drugs, From 2021 to 2026 (USD Billion)
  27. India Neurotherapeutics Market, By Neurologic drugs, From 2021 to 2026 (USD Billion)
  28. Asia-Pacific Neurotherapeutics Market, By Neurologic devices, From 2021 to 2026 (USD Billion)
  29. Asia-Pacific Electroconvulsive Therapy (ECT) Market, By Region, From 2021 to 2026 (USD Billion)
  30. Asia-Pacific Vagus Nerve Stimulation (VNS) Market, By Region, From 2021 to 2026 (USD Billion)
  31. Asia-Pacific Transcranial magnetic stimulation Market, By Region, From 2021 to 2026 (USD Billion)
  32. Asia-Pacific Deep Brain Stimulator Market, By Region, From 2021 to 2026 (USD Billion)
  33. Japan Neurotherapeutics Market, By Neurologic devices, From 2021 to 2026 (USD Billion)
  34. China Neurotherapeutics Market, By Neurologic devices, From 2021 to 2026 (USD Billion)
  35. India Neurotherapeutics Market, By Neurologic devices, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample